Proliferation Of Scientific Prizes Reinforces Nobel's Distinguished Honor

Prizes in science-especially those with large honoraria-are proliferating. In North America alone, some 3,000 prizes are available in the sciences-five times as many as 20 years ago. In the same interval, the population of working scientists has grown, but at nothing like that clip. Like their predecessors, most new prizes are designed to honor those who have done significant research and, as a byproduct, to honor those who award them. Unlike most of their predecessors, many new prizes are ric

Written byHarriet Zuckerman
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Prizes in science-especially those with large honoraria-are proliferating. In North America alone, some 3,000 prizes are available in the sciences-five times as many as 20 years ago. In the same interval, the population of working scientists has grown, but at nothing like that clip.

Like their predecessors, most new prizes are designed to honor those who have done significant research and, as a byproduct, to honor those who award them. Unlike most of their predecessors, many new prizes are rich. More than two dozen of them bring recipients $100,000 or more. Both the Japan Prize for Science and the Lemelson-MIT Prize for Invention recently had honoraria of $500,000. Other such awards include the Kyoto Prize for basic science of $430,000, the Charles Stark Draper Prize for engineering of $400,000, the Crafoord prizes of $340,000 each, and the Bower Prize for science of $250,000.

Illustration: John Overmyer An additional half-dozen new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies